Production of 177Lu for Targeted Radionuclide Therapy: Available OptionsAshutosh Dash, F. F. Knapp, M.R.A. Pillai|Nuclear Medicine and Molecular Imaging|2015Cited by 375
Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising PerspectivesNicolas Lepareur, F. F. Knapp|Frontiers in Medicine|2019Cited by 154
Sustained Availability of <sup>99m</sup>Tc: Possible Paths ForwardM.R.A. Pillai, F. F. Knapp, Ashutosh Dash|Journal of Nuclear Medicine|2012Cited by 140
Peptide Receptor Radionuclide Therapy: An OverviewAshutosh Dash, F. F. Knapp, Sudipta Chakraborty et al.|Cancer Biotherapy and Radiopharmaceuticals|2015Cited by 122
Rhenium-188: Availability from the 188W/188Re Generator and Status of Current ApplicationsM.R.A. Pillai, F. F. Knapp, Ashutosh Dash|Current Radiopharmaceuticals|2012Cited by 94